Stockscreener 앱 받기
22.58
4.12%
-0.97
전일 마감가:
$23.55
열려 있는:
$23.21
하루 거래량:
3.00M
Relative Volume:
1.08
시가총액:
$3.21B
수익:
-
순이익/손실:
$-412.89M
주가수익비율:
-5.8497
EPS:
-3.86
순현금흐름:
$-361.93M
1주 성능:
+31.89%
1개월 성능:
+78.50%
6개월 성능:
+91.52%
1년 성능:
-21.76%
1일 변동 폭
$22.23
$23.34
1주일 범위
$22.23
$25.00
52주 변동 폭
$6.36
$35.68
다인 테라 Stock (DYN) Company Profile
명칭
Dyne Therapeutics Inc
전화
(781) 786-8230
주소
1560 TRAPELO ROAD, WALTHAM
DYN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
22.58 | 3.35B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | -52.09M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
다인 테라 Stock (DYN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-25 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | 개시 | Bernstein | Mkt Perform |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-29 | 개시 | Evercore ISI | Outperform |
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-11-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-21 | 재확인 | Chardan Capital Markets | Buy |
| 2024-04-30 | 개시 | Morgan Stanley | Overweight |
| 2024-02-20 | 개시 | H.C. Wainwright | Buy |
| 2023-02-27 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | 개시 | Oppenheimer | Outperform |
| 2023-01-26 | 개시 | Guggenheim | Buy |
| 2022-07-20 | 개시 | Chardan Capital Markets | Buy |
| 2022-07-12 | 개시 | Raymond James | Outperform |
| 2020-10-12 | 개시 | JP Morgan | Overweight |
| 2020-10-12 | 개시 | Jefferies | Buy |
| 2020-10-12 | 개시 | Piper Sandler | Overweight |
| 2020-10-12 | 개시 | Stifel | Buy |
모두보기
다인 테라 주식(DYN)의 최신 뉴스
Historical volatility pattern of Dyne Therapeutics Inc. visualizedJuly 2025 PreEarnings & Intraday High Probability Alerts - newser.com
Sector ETF performance correlation with Dyne Therapeutics Inc.2025 Price Momentum & Smart Money Movement Tracker - newser.com
Can trapped investors hope for a rebound in Dyne Therapeutics Inc.July 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Analyzing Dyne Therapeutics Inc. with risk reward ratio charts2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com
Is Dyne Therapeutics Inc. stock entering bullish territory2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Technical analysis overview for Dyne Therapeutics Inc. stock2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Using RSI to spot recovery in Dyne Therapeutics Inc.2025 Winners & Losers & Technical Entry and Exit Tips - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryPortfolio Value Summary & Fast Exit and Entry Strategy Plans - newser.com
Is Dyne Therapeutics Inc. stock gaining market share2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com
What recovery options are there for Dyne Therapeutics Inc.Market Risk Analysis & Low Volatility Stock Suggestions - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervaluedGDP Growth & Stock Portfolio Risk Control - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidance2025 Dividend Review & Safe Capital Investment Plans - newser.com
How moving averages guide Dyne Therapeutics Inc. trading2025 Year in Review & Stock Timing and Entry Methods - newser.com
Is Dyne Therapeutics Inc. stock a bargain at current levels2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today - MSN
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis - MSN
Can you recover from losses in Dyne Therapeutics Inc.Recession Risk & AI Forecast Swing Trade Picks - newser.com
Dyne Therapeutics (NASDAQ:DYN) Shares Gap UpStill a Buy? - MarketBeat
10 Big Names Crushing Wall Street - Insider Monkey
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - Insider Monkey
다인 테라 (DYN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다인 테라 주식 (DYN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna | Chief Commercial Officer |
Sep 04 '25 |
Sale |
13.27 |
894 |
11,863 |
95,017 |
| Friedl-Naderer Johanna | Chief Commercial Officer |
Sep 05 '25 |
Sale |
13.41 |
144 |
1,931 |
94,873 |
| Kerr Douglas | Chief Medical Officer |
Sep 04 '25 |
Sale |
13.27 |
3,552 |
47,135 |
89,263 |
| Kerr Douglas | Chief Medical Officer |
Sep 05 '25 |
Sale |
13.41 |
873 |
11,707 |
88,390 |
1.62%
0.21%
자본화:
|
볼륨(24시간):